PPH (VanEck Pharmaceutical ETF) Stock Analysis - Insider Trades

VanEck Pharmaceutical ETF (PPH) is a publicly traded the market company. As of May 21, 2026, PPH trades at $102.63 with a market cap of $0 and a P/E ratio of 0.00. PPH moved +0.16% today. Year to date, PPH is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces PPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PPH stock inside the company?

Rallies tracks PPH insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

PPH Key Metrics

Key financial metrics for PPH
MetricValue
Price$102.63
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume125.21K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest PPH News

PPH Analyst Consensus

PPH analyst coverage data. Average price target: $0.00.

Common questions about PPH

Who is trading PPH stock inside the company?
Rallies tracks PPH insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for PPH?
Yes. Rallies tracks PPH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PPH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PPH. It does not provide personalized investment advice.
PPH

PPH